Neurogene (NGNE) Short-term Investments (2013 - 2026)
Neurogene's Short-term Investments was $112.91 million in Q2 2026, down 47.7% from $215.71 million a year earlier and down 5.1% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Short-term Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Neurogene came in at $165.17 million, down 6.1% from FY2024.
- In earlier years, Short-term Investments was $175.82 million in FY2024 (+259.2%) and $48.95 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q3 2024.
- Compared with a year earlier, Short-term Investments has declined for three straight quarters, with growth averaging 109.5% over the last seven quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q2 2025 (growth of 403.1%); the worst was Q1 2024 (a decline of 59.5%).
- Per Business Quant data, NGNE's Short-term Investments in the three quarters before Q2 2026 was $119.02 million (Q1 2026), $165.17 million (Q4 2025) and $194.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,142.38 Bn | 1,110.97 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.12 Bn | 554.98 Bn | 17.30 Bn |
| 3 | AbbVie | 500.65 Bn | 473.76 Bn | 12.70 Bn |
| 4 | Merck | 355.26 Bn | 309.64 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.41 Bn | 264.40 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.79 Bn | 237.48 Bn | 12.86 Bn |
| 7 | Amgen | 238.16 Bn | 193.56 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 170.34 Bn | 116.99 Bn | 10.94 Bn |
| 10 | Neurogene | 524.67 Mn | -478.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.91 Mn |
| Mar 31, 2026 | 119.02 Mn |
| Dec 31, 2025 | 165.17 Mn |
| Sep 30, 2025 | 194.41 Mn |
| Jun 30, 2025 | 215.71 Mn |
| Mar 31, 2025 | 221.83 Mn |
| Dec 31, 2024 | 175.82 Mn |
| Sep 30, 2024 | 72.36 Mn |
| Jun 30, 2024 | 42.87 Mn |
| Mar 31, 2024 | 19.39 Mn |
| Dec 31, 2023 | 48.95 Mn |
| Sep 30, 2023 | 53.28 Mn |
| Jun 30, 2023 | 50.95 Mn |
| Mar 31, 2023 | 47.94 Mn |
| Sep 30, 2022 | 66.54 Mn |
| Jun 30, 2022 | 38.93 Mn |
| Jun 30, 2018 | 3.01 Mn |
| Mar 31, 2018 | 26.05 Mn |
| Dec 31, 2017 | 56.05 Mn |
| Sep 30, 2017 | 72.59 Mn |
API Access
Neurogene Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();